Pancreatic cancer patients in England get CDF access to Abraxane

4th August 2017 Uncategorised 0

Patients with pancreatic cancer living in England can from today potentially get access to a new treatment option after funding for Celgene’s Abraxane was approved for NHS use.

More: Pancreatic cancer patients in England get CDF access to Abraxane
Source: News